These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 53884)

  • 1. [Malignant tumour-lymphocyte response to a human encephalolitogenic factor (author's transl)].
    Garrido F; Garcia-Puche JL; Osorio C
    Sangre (Barc); 1975; 20(3):255-60. PubMed ID: 53884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular immunity in neurological diseases. Results with myelinbasic protein (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Lehmitz R; Schmieter K
    Nervenarzt; 1979 Jan; 50(1):10-5. PubMed ID: 85265
    [No Abstract]   [Full Text] [Related]  

  • 3. Human T lymphocyte response to myelin basic protein: selection of T lymphocyte lines from MBP-responsive donors.
    Vandenbark AA; Chou YK; Bourdette D; Whitham R; Chilgren J; Chou CH; Konat G; Hashim G; Vainiene M; Offner H
    J Neurosci Res; 1989 May; 23(1):21-30. PubMed ID: 2473214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stimuli required for enhanced transfer of experimental allergic encephalomyelitis with myelin basic protein sensitized guinea pig peritoneal exudate cells.
    Fujii T; Driscoll BF
    Prog Clin Biol Res; 1984; 146():299-305. PubMed ID: 6201902
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies on antigenic regions of bovine encephalitogenic protein with the lymph node cell transformation test in rabbits.
    Bergstrand H; Källén B
    Neurobiology; 1974; 4(5):328-36. PubMed ID: 4138485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myelin proteins and demyelinating disease (author's transl)].
    Uyemura K; Kitamura K; Yamanaka T
    Tanpakushitsu Kakusan Koso; 1974 Oct; 19(11):1018-32. PubMed ID: 4140549
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
    Light PA; Preece AW; Waldron HA
    Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological study of in vitro PHA-and mixed lymphocyte cultures (author's transl)].
    del Pozo Pérez MA; Velasco Alonso R
    Sangre (Barc); 1976; 21(1):90-105. PubMed ID: 1265595
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual response of lymphocytes from multiple sclerosis patients to myelin basic protein.
    Wicher V; Olszewski W; Milgrom F
    Clin Exp Immunol; 1979 Jul; 37(1):114-9. PubMed ID: 90569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of the cellular composition of primary tumour cell suspensions on the in-vitro cultural growth rate with monolayer cultivation--a contribution to tumor-immunological interrelationships (author's transl)].
    Schönfelder M
    Arch Geschwulstforsch; 1975; 45(8):810-3. PubMed ID: 1230126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.
    Benezra D; Hochman A
    Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacterial toxin superantigens activate human T lymphocytes reactive with myelin autoantigens.
    Burns J; Littlefield K; Gill J; Trotter JL
    Ann Neurol; 1992 Sep; 32(3):352-7. PubMed ID: 1384422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selenium, aflatoxins and lymphocyte reactivity (author's transl)].
    Aleksandrowicz J; Lisiewicz J; Skotnicki A; Waszek Z
    Folia Clin Int (Barc); 1974 Nov; 24(11):795-6. PubMed ID: 4435282
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte responses to human tumor antigens: their role in cancer diagnosis.
    Moore M; Lajtha LG
    Int Rev Exp Pathol; 1977; 17():97-142. PubMed ID: 66217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent development for the application of fluorescence spectroscopy to cell biology: flow microfluorocytometry and fluorescence polarization (author's transl)].
    Fukumoto T; Tsuda H; Maeda H
    Iyodenshi To Seitai Kogaku; 1981 Apr; 19(2):79-93. PubMed ID: 7328875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Functional characteristics of lymphocytes and the response to encephalitogenic peptide in patients with cerebral infarct].
    Lesický O; Bartko D; Buc M
    Cesk Neurol Neurochir; 1987 Jul; 50(4):233-7. PubMed ID: 2444352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immune response to myelin basic proteins in patients with dilated cardiomyopathy].
    Aleksandrova LZ; Bakhov NI; Titov VN; Gervazieva VB; Naumov VG
    Ter Arkh; 1987; 59(12):51-7. PubMed ID: 2451862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification and characterization of skin reactive factor (SRF) in supernatants of human lymphocyte cultures stimulated by PHA (AUTHOR'S TRANSL)].
    Zschiesche ?W; Eisenhuth I; Küchler W
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):377-85. PubMed ID: 4282921
    [No Abstract]   [Full Text] [Related]  

  • 20. The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes.
    Feng JM; Fernandes AO; Campagnoni CW; Hu YH; Campagnoni AT
    J Neuroimmunol; 2004 Jul; 152(1-2):57-66. PubMed ID: 15223237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.